In our unwavering commitment to transform cancer care, The US Oncology Network (The Network) and Ontada, a McKesson business, have joined forces to support the Cancer Moonshot initiative. This collaborative effort aims to revolutionize oncology treatment by leveraging cutting-edge technology and enhancing interoperability through the advanced framework of the Enhancing Oncology Model (EOM).

The Cancer Moonshot Initiative: A Vision for the Future

The Cancer Moonshot initiative, reinvigorated in 2022, aspires to reduce cancer death rates by 50% over the next 25 years. It emphasizes the importance of having seamless access to critical medical information to improve patient outcomes. This initiative aims to support patients and caregivers by creating a reliable healthcare system, particularly through the standardization and interoperability of electronic health records (EHRs).

Pioneering Innovation in Oncology

Ontada has partnered with the Department of Health and Human Services’ Office of the National Coordinator for Health Information Technology (ONC), the National Institutes of Health (NIH), and the Centers for Medicare & Medicaid Services (CMS) to advance oncology data standards. Early on, Ontada made the strategic decision to adopt mCODE (Minimal Common Oncology Data Elements), an HL7 industry standard designed to compile a core set of structured data elements for oncology electronic health records (EHRs). The Ontada and CMMI teams have created a high-tech solution to facilitate the reporting of key clinical data elements for the EOM program. Furthermore, by utilizing standardized data bolstered by Artificial Intelligence (AI), they have achieved a more comprehensive data set that can be seamlessly delivered via FHIR-based API functionality.  This innovation supports interoperability, along with enhancing the accuracy and completeness of the data sourced from the EHR system. In turn, better access and utilization of this data leads to improved health outcomes and promotes health equity.

Pilot with Compass Oncology

In our ongoing commitment to advancing cancer care, The Network is thrilled to announce that Compass Oncology, utilizing iKnowMed as its primary EHR, will pilot Ontada’s innovative technology during the first performance period (PP1) of the Enhancing Oncology Model (EOM). The Compass Oncology quality improvement team, with their extensive experience as participants in the previous Oncology Care Model (OCM) program, possess a deep knowledge of quality reporting requirements and workflows essential for meeting program criteria successfully.

The Network’s participation in this pilot underscores our dedication to driving innovation in cancer care. By working closely with Ontada, The Network is contributing to the development of tools and practices that will enhance data accuracy, improve efficiency, and promote health equity across the oncology landscape.

The Benefits for Practices and Patients

Our collaborative efforts with the Cancer Moonshot initiative and other stakeholders are set to bring numerous benefits to oncology practices and patients:

  1. Enhanced Data Accuracy and Completeness: By standardizing data elements across EHRs based on FHIR, we ensure that healthcare providers have access to accurate and comprehensive patient information, facilitating better treatment decisions.
  2. Improved Efficiency: The implementation of AI/NLP technology will streamline data capture processes, allowing healthcare providers to focus more on patient care rather than administrative tasks.
  3. Promoting Health Equity: By ensuring that critical health information is accessible across different systems, we aim to improve care for patients in rural and underserved areas, thereby advancing health equity.
  4. Accelerated Research and Innovation: Standardized data opens new possibilities for faster research results and more effective public health interventions, driving continuous innovation in cancer care.

Our Commitment to Excellence

The Network’s dedication to the EOM program and the use of USCDI+ codes and FHIR API functionality underscores our commitment to advancing cancer care through technology. As a Qualified Clinical Data Registry-certified vendor for eight consecutive years, The Network has consistently demonstrated the ability to support and innovate within the oncology field. This year, we have also implemented Social Determinants of Health collection across 12 practices to support the EOM program.

Join Us in Shaping the Future of Cancer Care

As we advance in healthcare technology innovation, we encourage the oncology community to support and engage in efforts to make health information exchange more prevalent. The dedication and involvement of the healthcare community will propel us toward a more innovative, cohesive, and patient-centered future.

ABOUT THE AUTHORS

Wanmei Ou, Vice President, Product Life Sciences, Ontada: "Ontada's collaboration with The Network and the Cancer Moonshot initiative is a step towards revolutionizing cancer care. Through our cutting-edge AI technology and FHIR-compliant common data model, we are not only addressing critical interoperability challenges but also promoting health equity and accelerating research in oncology."

Erin Crum, Senior Director, Quality Strategy and Innovation, The Network: "Our partnership with Ontada and the Cancer Moonshot initiative exemplifies our commitment to transforming oncology care. By leveraging advanced AI and interoperability, we are pioneering innovations that enhance data accuracy and improve patient outcomes, ultimately driving significant advancements in cancer treatment."

Scott Rushing, MD, MBA, Practice President, Compass Oncology: “Compass Oncology is excited to participate in this groundbreaking pilot with The Network and Ontada. This initiative will enhance our practice by leveraging advanced AI technology and improving data interoperability, ultimately leading to better patient outcomes and more efficient cancer care."

Gaps in health equity can contribute to sub-optimal outcomes

Maximizing the opportunities of achieving the best possible outcomes for cancer patients goes beyond the confines of the clinic. Addressing the needs of patients requires understanding and overcoming challenges related to socioeconomic factors and the environment. These challenges, often referred to as Social Drivers of Health (SDoH), encompass the conditions in the environments where people are born, live, grow, eat, play, and die.

SDoH can significantly impact an individual’s health outcomes and overall quality of life, as well as their access to quality medical care. When patients face obstacles in any of these areas, seeking healthcare or following through with their treatment plans becomes difficult. Therefore, it is crucial to help patients overcome these challenges and remove barriers that hinder their ability to concentrate on their treatment.

By assessing and addressing SDoH, we can enhance patients’ access to care and promote optimal outcomes. This approach not only improves their quality of life but also contributes to a more equitable healthcare system. By focusing on the needs of cancer patients beyond the clinic, we can make a significant impact on their treatment journey and ultimately improve their chances of achieving the best possible outcomes.

Challenges addressing SDoH barriers in community oncology

Addressing SDoH barriers comes with its own set of challenges for community oncology practices. Limited staff, tight budgets, and short appointment times make it difficult to comprehensively screen and connect patients with resources. Additionally, navigating fragmented social service systems and respecting patient privacy can add further complexity. In particular, rural community oncology practices must find innovative solutions to overcome these difficulties, which may be less accessible in rural areas, and ensure that patients receive the support they need to address their SDoH barriers.

Three practices in The US Oncology Network (The Network) – Shenandoah Oncology, Southern Cancer Center, and Willamette Valley Cancer Institute & Research Center – have experienced firsthand the difficulties patients encounter in accessing the resources needed to address SDoH barriers. Navigators had to manually search for social service programs, often finding outdated or inactive options, causing delays in connecting patients with appropriate services and causing frustration. Additionally, the limited availability of programs further hindered the ability to find solutions tailored to each patient’s specific needs.

Despite these hurdles, there’s growing support for integrating SDoH efforts into community oncology practices, with resources being developed to help connect patients with social services in their community. The Network has made it a priority to help patients address SDoH barriers so they can access high quality care, within their community.

Connecting patients to social services with The Network and Findhelp

To address the increasing socioeconomic and environmental challenges faced by cancer patients, The Network has partnered with Findhelp, a platform that assists in navigating social services, community resources, and referrals for patients. This collaboration allows for a more comprehensive level of support, efficiently connecting patients with the necessary assistance they require. By doing so, it promotes optimal outcomes for individuals who are often disadvantaged by various circumstances, thereby bridging the gap in health equity.

The implementation of Findhelp has brought significant improvements to Shenandoah Oncology, Southern Cancer Center, and Willamette Valley Cancer Institute & Research Center in their quest to connect patients with the social services they need. The platform has transformed the referral process, allowing practices to track the availability and activity of programs, ensuring patients are referred to active and relevant services. The ability to filter programs based on eligibility criteria has significantly improved efficiency, eliminating the need for manual searches through irrelevant options. Findhelp has also expanded the range of available programs, empowering navigators to educate patients on how to utilize the platform effectively to find the assistance they require. This has not only increased the accessibility of resources for patients but also enhanced the overall patient experience.

By implementing Findhelp, The Network has successfully addressed the challenges practices faced prior to its adoption. The result is a streamlined referral process, improved patient access to vital resources, and increased efficiency for navigators. From June 2023 to June 2024 practices in The Network referred 3,116 patients to community-based social services. Findhelp has truly made a positive impact on practices in The Network, enabling them to provide comprehensive and effective support to their patients.

The Network’s ongoing commitment to empowering patients through addressing SDoH barriers

The Network is dedicated to making a significant impact in addressing SDoH barriers. With a firm commitment to this cause, The Network aims to increase closed loop referrals, a process in which Findhelp refers a patient to an agency and then follows up to ensure that the referral was completed and that the necessary services were provided, within 30 days post-referral by an impressive 65% during Fiscal Year 2024. This commitment is projected to positively impact over half a million patients, ensuring they receive the necessary support and resources to overcome SDoH barriers.

By actively working towards increasing closed loop referrals, practices in The Network demonstrate their dedication to providing comprehensive care to patients. This commitment will not only improve patient outcomes but also contribute to the overall well-being and quality of life for those facing cancer and SDoH challenges. The Network is proud to take a leading role in addressing SDoH and ensuring that patients receive the holistic support they need throughout their cancer journey.

By The Network’s editorial staff

As cancer care evolves at an increasingly rapid pace, The US Oncology Network stands at the forefront of community oncology, dedicated to advancing care and enhancing patient outcomes. Leading this charge is our new president Devon Dickey Womack, whose appointment marks a significant milestone in our journey towards setting new standards in oncology care. With an unwavering commitment and a visionary approach, she is poised to steer The Network through its next phase of growth and innovation, ensuring that we support practices as they continue to deliver best-in-class care.

With a 14-year tenure with The Network and McKesson, Devon is a familiar face and brings deep expertise and dynamic leadership to her new role. Most recently as the chief operating officer of The Network, she made great strides in ensuring practices have the resources they need to operate efficiently and deliver cost-effective, high-quality patient care. She led the launch of The Network’s “Time to First” strategy to improve patient access. Through this initiative, more than 70% of practices in The Network reduced the time for patients to complete their first consult with their oncologist.

Additionally, Devon continues to pave the way for research expansion with eleven practices in The Network entering into new research agreements with Sarah Cannon Research Institute (SCRI).  We are already exceeding our initial treatment trial accruals goal, starting the fiscal year off strong. Our goal is to ensure that more patients have access to modern cancer therapies and treatment trials. Advancing cancer research to make these therapies a reality for everyone happens in the community setting.

Devon is deeply committed to the development and support of oncology practices and their ability to deliver top-tier care, aiming to support more than 25% of cancer patients across the nation. Under her leadership, The Network is continuing to double down on its focus on patient care models that encompass not only state-of-the-art treatments but also psychological and social support for patients and their families.

As she takes the helm of The Network, Devon is enthusiastic about the potential for transformative change in community oncology. Her vision encompasses a broad spectrum of initiatives aimed at enhancing patient care through technological innovation, precision medicine, operational excellence and practice growth.

“There is much to be optimistic about in the future of community oncology. Our commitment lies in providing cutting-edge care, right in your own backyard,” says Devon. “Together, we will ensure that patients receive world-class treatment, while fostering an environment where practices, physicians and care teams can thrive and make a lasting impact on their communities.”

As we embark on this exciting new chapter under Devon’s leadership, The Network is positioned not only to meet the current demands of oncology care but to anticipate and respond to future challenges. Her strategic vision, coupled with a relentless dedication to excellence, will guide The Network as the leader in community oncology, setting the standard for care, compassion and innovation.

By Marcus Neubauer, MD, Chief Medical Officer

The Network was thrilled to host another installment of our Annual Conference last month in Indianapolis. It’s always hard to top the previous year, but we just may have on the heels of tremendous growth of The Network and the excitement for what we are accomplishing together.

The Annual Conference is our signature event, and we were honored to host leaders from practices in The Network as we came together to hear insights on trends in oncology and network with our peers. I feel more energized than ever after the conclusion of the event and know that many who attended feel the same way. The power of The Network was palpable!

Here are a few of my takeaways from this year’s Annual Conference:

The tenacity and ingenuity of practices in The Network is remarkable

The theme of this year’s conference was “the power of community in action” – and I heard countless examples of how practices in The Network are living this every day. When a challenge is identified with the patient experience or clinic workflows, we work together to develop innovative and enduring solutions.

A great example was one that Jason Hammonds shared in his opening session: an initiative at Texas Oncology to redefine how the practice engages with new and existing patients. It is called “Project Touchpoint” and it is a first-of-its-kind, customized platform that uses AI-generated phone triage to capture incoming calls and solve for the issue on the first call. This has shown to significantly reduce unanswered calls.

Across The Network, the patient experience is at the core of innovation and Devon Womack spoke in her session about the investments we are making in this area. Devon reported on a Network-wide initiative to reduce the time to schedule new cancer patients.

We are making tremendous strides in advancing therapies for patients through research

We recently marked the first full year of our joint venture with Sarah Cannon Research Institute (SCRI), a partnership that is elevating clinical cancer research and advancing therapies available for patients. At the Annual Conference, we heard through a panel presentation that more trials are now available to practices in The Network and time to open a trial is much faster with SCRI.  This leads to more clinical trial opportunities for patients.

In addition, Genospace is helping practices in The Network solve one of the most complex challenges in research – identifying eligible patients. Among Genospace’s many functions is the ability to connect biomarker test results with each practice’s clinical data from their electronic health record. This provides advanced clinical trial matching and we’re already seeing practices realize the results of leveraging this technology. We will continue to see more synergies with SCRI and more benefits to the patient as time progresses.

Our focus on precision medicine is ensuring patients receive the most effective treatment possible

In The Network, we’ve been developing a cutting-edge precision medicine program that supports practices in ordering biomarker tests and the use of targeted therapies. Trends presented at the Annual Conference show that this program is taking off.

The team has focused their efforts in three areas: education, workflow and technology. Spanning these areas is the implementation of a genomic ordering module within iKnowMed℠, our oncology electronic health record, to provide practices with National Comprehensive Cancer Network® (NCCN®) testing alerts at the time of diagnosis and staging. The team is also utilizing Genospace for automated biomarker result integration and is continuing to build out the shared capabilities between our organizations. This work is ensuring more patients are receiving the most effective treatments.

While I’ve shared three takeaways here, we discussed a number of other topics at the Annual Conference, including value-based care, public policy, best practices and more. The expertise and the passion in The Network is unmatched and it’s wonderful to be reminded of our collective power when we come together!

ABOUT THE AUTHOR


Marcus Neubauer, MD
Chief Medical Officer


by Jason Hammonds, president

2023 has been a landmark year for The US Oncology Network, marking new heights in our mission to provide premier care to patients in local communities across the nation. We’re proud to share more about what we’ve accomplished this year.

Expanding The Network’s footprint through both additions and renewals

In 2023, The US Oncology Network experienced a year of tremendous growth, adding six new practices and expanding into four new states and with this growth, our footprint has extended to over 600 sites of care across 30 states. We are committed to providing high-quality care close to home, and this growing footprint greatly enhances The Network’s ability to do so by providing practices with the resources to succeed and thrive, all while remaining independent. With more than 2,500 providers treating over 1.4 million patients annually, our belief that local cancer care is better care is being put into practice every day.

Not only is The Network adding new practices, but we are also pleased to share that we had six practices within The Network renew their agreements with us over the last 18 months, reaffirming that our commitment to provide each practice in The Network with tailored support and services that meet their needs is being accomplished.

Strategizing to meet the growing patient demand

Continued innovation in how we support practices in The Network is paramount for our organization. One of our areas of focus this year has been increasing access to the premier care provided in The Network. We know that demand for oncology care continues to rise, and we want to make sure that we are optimizing resources in order to meet this demand. As the demands on practices and staff evolve, so does our approach, such as effectively using advanced practice providers and leveraging telehealth technologies, and we’ve seen a shared dedication to this effort across practices in The Network. These efforts combined with our newly affiliated practices have resulted in an approximately 20% increase in patient visits across our practices from the prior year. We’re looking forward to continuing to work with each practice so that we can ensure patients – no matter their location – can receive high-quality cancer care.

Leading the conversation in oncology care

Thought leaders in The Network played a role in important conversations in oncology throughout the industry this year and were featured in nearly 250 publications, including OncLive, Journal of Clinical Pathways, American Journal of Managed Care, CURE, Targeted Oncology and Oncology Times, just to name a few. Topics ranged from increasing patient access, to the importance of physicians becoming advocates, to value-based care strategies.

And teams across our organization hosted a number of events for our community in The Network to come together to discuss industry trends and share best practices. This included The Network’s signature event, the Annual Conference, and other events like the National Policy Board Executive Committee Retreat, the Payer Transformation Summit, and more.

Delivering on our commitment to value-based care

The Network is proud that 12 practices and over 1,500 providers are participating in the Enhancing Oncology Model (EOM). These practices committed to implementing all required EOM participant redesign activities (PRAs) at the 90-day mark and have focused on the core essentials of the model including care & treatment plans, initial drug initiatives, enrolling patients & billing MEOS (monthly enhanced oncology service payments), appropriately capturing comorbidities, and developing risk management strategies for the program. Through close collaboration with the Center for Medicare and Medicaid Innovation (CMMI) EOM leadership, we’ve partnered on engaging EOM Townhalls and strategic leadership meetings, fostering a dynamic exchange of ideas and feedback that is driving innovative advancements in oncology treatment and patient care. 

Another important value-based care initiative this year was the collaboration between The Network’s Texas Oncology and Carrum Health as they came together to provide exceptional breast cancer care to patients. This new collaboration offers a bundled package for breast cancer care that includes two years of coverage for chemotherapy, radiation, and symptom management from Texas Oncology. Texas Oncology is one of Carrum’s rigorously vetted Centers of Excellence, comprising high-value providers who prioritize patient-centric, evidence-based care nationwide. Carrum offers its employer clients access to pre-negotiated bundled prices, providing members with peace of mind and dedicated care navigators to help them navigate their treatment journey while reducing worrying about costs and administrative burdens.

From EOM to Carrum Health and over 90 other commercial Value Based Care (VBC) agreements, practices in The US Oncology Network continue to serve as leaders in VBC arrangements.  These groundbreaking programs have galvanized our teams, unleashing a wave of innovation that is reshaping the future of community oncology care.  We continue to partner with practices on VBC adoption, total cost improvement, proactive care management, and health equity all driving improved quality care for patients.

Transforming oncology research through collaboration

This year marked The Network’s first full year of our joint venture with Sarah Cannon Research Institute (SCRI), a partnership with the potential to transform oncology clinical research. Throughout this period, our primary focus has been on effectively navigating and maximizing the potential of this collaboration. SCRI is renowned for its expertise in clinical research and innovation, making it an ideal partner for The Network’s goal to provide more access to research and clinical trials in the community setting. Together, we are working to leverage our respective strengths and resources, aiming to enhance patient care and drive advancements in medical research. In 2023 year to date, we have participated in over 200 clinical trials across The Network and more than 800 patients have been enrolled in interventional, treatment studies. In this partnership, we are fostering a culture of collaboration, enabling us to explore new avenues and approaches in the pursuit of growing clinical trial access by expanding our trial menu and increasing patient enrollments. As we reflect on this milestone and look to next year, we are proud of the progress we have made and excited about the future possibilities that lie ahead.

Advancing precision medicine with biomarker testing

Over the past year, our precision medicine program pursued an important goal: increasing biomarker testing across practices in The Network to increase appropriate utilization of targeted therapies. This work aims to integrate cutting-edge precision medicine support and tools into practice workflows to ensure patients receive the most effective treatment possible. We have successfully implemented a genomic ordering module within iKnowMedSM G2 to help provide our oncologists with National Comprehensive Cancer Network (NCCN) testing recommendations based on the patient’s diagnosis and stage. The program also established electronic interfaces with key labs to enable integration of genomic test results into iKnowMed in both PDFs and structured fields. Ultimately, the goal of the precision medicine team is to improve patient outcomes by providing our practices with the tools, support, and education needed to navigate the complexities of biomarker test selection and results interpretation. In the year ahead, the team will expand their work to include a precision medicine analytics platform to track key performance metrics such as testing rates by diagnosis and utilization of appropriate targeted therapies, and the implementation of a genetic testing screening tool within the iKnowMed workflow. 

Looking forward

As you can see, there’s a lot of exciting things going on in The Network – and this is only a snippet of all that we are accomplishing together. I’m tremendously excited to continue to work together with practices in The Network to advance the oncology landscape and deliver high-quality care to all patients. 

ABOUT THE AUTHOR

Jason Hammonds, President of The US Oncology Network

Jason Hammonds
President, The US Oncology Network 

 

By Lalan Wilfong, MD, senior vice president, Payer & Care Transformation, and Stuart Staggs, senior director, Strategic Programs

Engaging with the Enhancing Oncology Model (EOM), the successor to the Oncology Care Model (OCM), is a natural progression for The US Oncology Network (The Network), as we remain dedicated to leading the way in delivering patient-centric redesign activities, enhanced services, and quality outcomes, while striving to achieve sustainable cost of care for oncology.

We are proud to share that 12 practices representing more than 1,000 physicians in The Network are participating in the EOM. This means that over 70% of physicians in The Network are participating in this new model. We are committed to continuing to provide practices in The Network coordinated resources and transformation strategies to enable success in value-based care models.

Though no model is perfect and tackling total cost risk on day one is a real concern, the EOM reinforces the importance of remaining hyper-focused on equal and easier patient access to care and bending the total cost curve for the future of oncology care.

We look forward to continuing to reinforce The Network’s commitment to high-quality patient outcomes and equal access to care at a sustainable cost.

We are pleased to announce that the practices in The Network participating in EOM are:

 

ABOUT THE AUTHORS


Lalan Wilfong, MD
Senior Vice President, Payer and Care Transformation


Stuart Staggs
Senior Director, Strategic Programs

By Marcus Neubauer, MD, Chief Medical Officer

Our Annual Conference at the end of last month marked our first in-person event for The Network since before the pandemic, and it was so energizing to feel the collective power of The Network as leaders, physicians, and clinicians came together to connect with peers and learn about new developments both in The Network and across community oncology.

This year’s conference included expert panels, breakout sessions, a dynamic keynote speaker, and, perhaps most importantly, face-to-face interactions among peers. The Annual Conference is an exclusive opportunity for member practices in The Network to gain actionable insights they can immediately put to work in their practices to benefit the operational and financial health of their business and enhance patient care. The oncology landscape is rapidly evolving, and we were fortunate to hear from our experts in the field on topics that included surgery, radiation, value-based care, precision medicine, clinical trials, public policy and more.

As I reflect back on the event, here are my takeaways:

The power of The Network is immense – and growing

In Jason Hammonds’ opening session, he shared that The Network is experiencing one of its strongest periods of growth, welcoming nearly 500 providers in the past year and making The Network over 2,300+ providers strong. The evolution of The Network is evident in our support of practices as they expand their footprints as well as adding new practices in new geographies to our collective power.

And the need for community oncology is growing, as more patients look for high-quality, cost-effective care close to home. Practices in The Network are well positioned to rise to the demands of what patients need in the coming years.

Across The Network, we have a keen focus on expanding patient access and enhancing the patient experience

The patient is at the center of everything we do – and I heard this thread run throughout our conference.

Devon Womack detailed in her session how one of our top priorities is to reach more patients and reduce the operational burden on practice staff by using technology in new, innovative ways. Sydney Townsend shared her own personal cancer story and how that propelled her into her current role at Texas Oncology where she is focused on initiatives to transform the patient experience, such as advancing digital health tools and expanding supportive care services.

While the business of oncology care is complex and the services that The Network provides to practices are comprehensive, it was invigorating to hear colleagues in different roles across the organization echo a shared vision for how we can continue to be a leader in providing oncology care close to home – all in service of the patient at the center of what we do.

Innovation will propel us forward

Finally, it was exhilarating to learn more about the countless ways our teams are innovating to meet the current needs of practices and patients and also preparing for the future.

Innovation is a key priority for The Network, and Jason shared more about investments that the business has made in areas such as personalized medicine and interoperability. But innovation is also happening in teams across The Network, and I was struck by the dedication of colleagues to think about old problems in new ways!

I left the Annual Conference with a feeling of pride to be a part of The Network – and excited about what is to come. It had been four years since we last held The Network’s Annual Conference due to the disruption of the pandemic and it was great to interact with the leaders from practices in person.

Until next time!

ABOUT THE AUTHOR


Marcus Neubauer, MD
Chief Medical Officer

By Lalan Wilfong, MD, SVP, Payer & Care Transformation and Stuart Staggs, Sr. Director, Strategic Programs

After six years of dedicated effort to deliver high-quality care at a more sustainable cost, we’re pleased to share final Oncology Care Model (OCM) results from practices in The US Oncology Network (The Network). The practices’ dedication to value-based case resulted in an improved experience and better outcomes for ~130,000 unique Medicare patients. Since 2016, Medicare OCM patients treated in these practices in The Network realized a 37% reduction in inpatient stays, 18% decrease in emergency room visits, and a 6% increase in access to hospice >3 days before end of life.

Care teams in The Network improved access to patient services; specifically navigation, social work, nutrition, financial counseling, survivorship, advance care planning, and palliative care to ensure patients receive the right care at the right time. Treatment plan adoption led to more targeted shared decision-making conversations to help ensure patients are aware of what to expect throughout treatment and anticipated outcomes. Drug initiatives, with biosimilar conversion at the helm, made it possible to bend the total cost curve while remaining focused on evidence-based outcomes. Even as COVID impacted everyone during the latter half of the OCM, practices continued to make great strides on improving quality while enabling patient access to essential care and support services.

And practices in The Network proved that quality oncology care can be delivered while also bending the total cost curve. Over the life of the OCM, practices in The Network saved Medicare $337M compared to the benchmark amount. More than half of practices in The Network participating in the OCM were confident enough in their efforts to voluntarily pursue two-sided risk. This is a testament to the practices’ leadership and commitment to value-based care, and to their partnership with The Network, which aims to instill confidence in practice and care transformation. The momentum from the OCM contributed to a marked increase in value-based care (VBC) initiatives, and we now have over 70 different VBC commercial programs across The Network.

We are looking ahead to the Enhancing Oncology Model (EOM), the successor to the OCM, that will launch in July 2023 – and we’re working hard to ensure that practices in The Network are equipped with the knowledge, processes, analytics and technology to be successful in this program.

ABOUT THE AUTHORS


Lalan Wilfong, MD
Senior Vice President, Payer and Care Transformation


Stuart Staggs
Senior Director, Strategic Programs

by Jason Hammonds, president

2022 was a year of tremendous growth for The US Oncology Network – and we’ve kicked off 2023 by announcing that two new practices have joined our organization. As we’re growing, we’re not only welcoming new physicians, providers, and practices, but we’re also expanding capabilities, insights and collaboration in support of our unwavering mission to advance community oncology care and keep independent community oncologists flourishing.

Now more than 2,000 providers strong, The Network continues to provide unparalleled clinical tools, financial security, comprehensive operational support and value-based care expertise, all while allowing physicians to remain independent and provide outstanding care for patients close to home.

I’m incredibly proud of what The Network is accomplishing together. This not only includes growing the business to ensure more patients receive care close to home, but also leading the way in key initiatives such as value-based care, precision medicine and clinical research. Let’s take a look back at our past year.

Strength in numbers

Over 280 providers joined The Network in 2022, making us even better equipped to provide care to more patients. And as we grow, we deepen our collective expertise, expand our network of collaboration, and build upon the breadth of resources that we can provide to practices and the patients they serve.

We also had several practices, including Missouri Cancer Associates, Shenandoah Oncology and Maryland Oncology Hematology, renew their management agreements with The Network.

“Being a part of The US Oncology Network has helped our practice remain strong and deliver comprehensive care to our patients,” shared Dr. George Sotos, president, Maryland Oncology Hematology. “We have benefited from The Network’s extensive operational and clinical solutions, including strategic planning support, revenue cycle optimization and efficient drug management.  We have access to both a wide range of promising novel therapies through the research program, and to the collective knowledge of 2,000 providers in The Network.  These capabilities mean that together, we can provide expert, state of the art cancer care to our patients, in their communities, now and in the future.”

You can read about the ways we have helped our practices succeed here.

Shaping the future of cancer care

Physicians in The Network continue to stand out as thought leaders in the industry and were included in over 250 leading publications such as the Journal of Clinical Oncology, American Society of Clinical Oncology, American Journal of Managed Care, and The Hill, just to name a few.

Many physician across The Network have also taken on leadership roles within the industry, including: Dr. Debra Patt, who was recently elected to serve as the Vice President of the Community Oncology Alliance (COA) and elected to join the American Society of Clinical Oncology (ASCO) Board of Directors; Dr. Moshe Chasky, who was elected to serve on the COA Board of Directors, and Dr. Barry Brooks, who sits on the National Community Oncology Dispensing Association (NCODA) Executive Council. As part of The Network’s power, we give independent physicians a platform to share their insights and expertise to help further advance initiatives for patients and providers.

You’ll find highlights from our news coverage here. Thank you to these experts for sharing their perspectives and shaping the future of cancer care.

New initiatives to enhance the power of The Network

As quickly as healthcare is evolving, we are also continually undertaking new initiatives to ensure The Network is at the forefront of care. This year, we:

  • Grew our surgical service line, helping our practices provide comprehensive care for patients along the entirety of their journey
  • Completed investments to enhance interoperability capabilities, making provider workflows more efficient and ensuring our practices are even better connected with referring physicians
  • Continued to invest in and develop a predicine medicine platform, including ease of ordering comprehensive genomic tests accompanied by clinical decision support tools
  • Executed on numerous group purchasing organization (GPO) strategies that led to differentiated value for our practices and expanded medically integrated dispensing (MID) capabilities with projects such as Integrated Rx to reach even more patients
  • Had an astounding twenty-five practices apply to the Enhancing Oncology Model (EOM), demonstrating our ongoing commitment to value-based care and improving outcomes
  • Delivered industry-leading results in the Oncology Care Model (OCM) as well as in innovative commercial payer programs, like our five-year collaboration with Blue Cross and Blue Shield of Minnesota
  • Established a joint venture between US Oncology Research and HCA Healthcare’s Sarah Cannon Research Institute, creating a comprehensive clinical research services organization focused on increasing access to clinical trials and bringing together more than 1,300 physicians who are providing access to clinical trials at more than 250 locations in 26 states across the U.S.

Kicking off 2023 by welcoming two new practices

We’re looking forward to another year of growth in 2023 and have begun the year by announcing that two new practices, Epic Care and Nexus Health, have joined The Network. With the addition of these multidisciplinary practices, we are entering new communities in Santa Fe, New Mexico and California’s East Bay, respectively, and expanding our ability to empower high-quality care in the community.

I can’t wait to see what this year brings as we continue to enhance the power of The Network and support our partner practices in achieving their strategic objectives.

ABOUT THE AUTHOR

Profile photo of Jason Hammonds Jason Hammonds has served as the President of The US Oncology Network since 2021. He has supported The Network for more than 15 years in a range of leadership roles.

 

 

 

As the largest participant in the Oncology Care Model (OCM), representing over 25% of total physician participation and nearly $250 million in combined savings to Medicare, The US Oncology Network welcomes the release of the Enhancing Oncology Model (EOM).

“While we are continuing to review the details of the EOM, we are pleased The Centers for Medicare & Medicaid Services Innovation Center (also known as “CMMI”) is pursuing a voluntary, physician-driven, oncology-specific model that emphasizes health equity,” said Dr. Marcus Neubauer, chief medical officer, The US Oncology Network. “The development and implementation of the OCM was a very collaborative process between CMMI and the stakeholder community, and we look forward to continuing that collaboration to ensure successful participation in this new model.”

The EOM contains new challenges—in comparison to the OCM, the EOM entails more down-side risk, covers a smaller population, and has a lower monthly enhanced oncology services (MEOS) payment, but it also represents a strong step forward on the path toward value-based care.

Every May, we celebrate Oncology Nursing Month to recognize the critical role oncology nurses play in patient care. Despite the challenges of recent years, nurses have continued to show up for patients with fierce dedication and compassion.  

This year’s theme, “The hands and hearts of hope,” reminds us that nurses are often a source of strength and hope for their patients and loved ones. And oncology nurses give hope to their patients and families while they travel through their cancer journey with a gentle touch before a procedure, a kind word in passing, or by comforting a patient or family member at the end of a journey. Oncology nurses tirelessly lead with expertise and compassion while providing hope and comfort for those facing the unimaginable. 

Nurses have been a sense hope since the dawn of the profession, but in the last two years, they have had to juggle more than ever while caring for patients with cancer and the challenges of the pandemic. Through it all, they continue to make personal sacrifices and preserve for their patients. 

We honor all oncology nurses for their dedication, commitment, and passion for helping those in need. Nurses play a key role in their patients’ cancer journey from explaining a diagnosis, to providing guidance through treatment, celebrating victories, and comforting patients through inconceivable setbacks. Even when faced with the most difficult situations, oncology nurses remain fearlessly committed to provide endless compassion and comfort to patients. 

The Network recognizes the important role nurses play in providing the highest quality patient care in a community setting and we are committed to supporting the professional growth and development of all our nurses and clinical staff. Nurses in The Network have access to clinical education programs, various certification courses,  wellness resources and on-going opportunities for leadership development. 

We thank you and celebrate all nurses of The US Oncology Network and beyond during Oncology Nursing Month, and every other day of the year. Thank you for all you do day in and day out! 

 

ABOUT THE AUTHOR
Judi Payne-De Bock, BSN is the senior director of Clinical Services for The US Oncology Network. She is responsible for leading The Network’s clinical services team and ensuring nurses and clinical staff at practices in The Network have the resources and support needed to provide high-quality patient care every day..

 

 

Value-based care can drive meaningful improvements in patient care by aligning payment with value. While many payers have value-based care programs, differences in structures and requirements can leave practices with an unbalanced focus on program requirements. Creating a quality and value-based care strategy allows practices to harmonize various programs ensuring high-quality patient care while minimizing practice burden.

 Creating a Quality Strategy

Successful performance in value-based care programs can be defined as improved quality of patient care and outcomes, a reduction in the cost of care for patients, payers, and employers, and the realization of financial benefits tied to performance. Creating an overall quality strategy keeps the practice focused on the key initiatives that can drive performance across programs.

  • Build a strategy team that is inclusive and meets the requirements of the value-based program in which you are participating. Practices can no longer count on a single quality lead to manage performance; developing a strategy is a team effort and may include various practice members, as well as a quality committee with clinical and administrative stakeholders.
  • Map out the requirements for all value-based care programs. Compare the similarities and differences in the data elements used to measure practice performance. Analyze how the score is calculated, and the methodology used to determine the financial benefit associated with the score.
  • Review the current performance for each program, at the practice and individual provider level, to see where improvement is needed.
  • Form your strategy by starting with high-level key drivers such as access to care, NCCN guidelines, care coordination, and end of life care, then drill down to the individual requirement and measure for each of the areas to identify specific action items for staff. Keep the patient perspective and care improvement at the forefront as you determine the priorities.

 Physician Engagement and Communicating the Quality Strategy

Once the quality strategy is created, a communication plan should be developed. Engage physicians and practice leaders first, then share the value-based care program overview and high-level details with the quality committee and other relevant practice committees. Share the value-based care program in detail with all providers and staff at each clinic. Team members responsible for change processes or creating new workflows should be engaged and help in communicating the new value-based care program including process, metric collection and monitoring, and ongoing performance. Updates should be shared consistently with the quality committee and sites on a consistent basis.

In addition to having a quality strategy in place, physician engagement is key to value-based care program success. When adding to or altering a physician routine, keep improved patient care and physician engagement at the forefront.  As physicians are challenged with shifting priorities, value-based care leads should keep them engaged rather than overwhelmed.

Practices that form an overall quality strategy and juggle the complexities of multiple programs will improve patient care and realize financial gains.

Learn more about managing value-based care programs here.

 

ABOUT THE AUTHOR
Toni Gress
Toni Gress is the Commercial Value Based Care Lead for The US Oncology Network. She collaborates with Managed Care and the Transformation Leads to lead The Network practices in successful participation and performance in value-based commercial programs with the goal of improving quality and total cost for patients, providers, practices and payers.
Jay Scott is the Senior Director of Managed Care for Minnesota Oncology, a practice in The US Oncology Network. He is responsible for the development of patient experience strategy and quality improvement plans aimed at continuous improvement for patients, providers, payers and practices.